ARTICLE | Company News
Caliber Biotherapeutics, iBio deal
February 25, 2013 8:00 AM UTC
iBio granted Caliber a non-exclusive license to use iBio's iBioLaunch plant-based vaccine and therapeutic protein manufacturing platform to develop and commercialize biopharmaceuticals against targets...